Hui Jia

640 total citations
10 papers, 488 citations indexed

About

Hui Jia is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Hui Jia has authored 10 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Hui Jia's work include Viral-associated cancers and disorders (7 papers), Cytomegalovirus and herpesvirus research (4 papers) and Immune Cell Function and Interaction (4 papers). Hui Jia is often cited by papers focused on Viral-associated cancers and disorders (7 papers), Cytomegalovirus and herpesvirus research (4 papers) and Immune Cell Function and Interaction (4 papers). Hui Jia collaborates with scholars based in United Kingdom, Hong Kong and China. Hui Jia's co-authors include Alan B. Rickinson, Graham S. Taylor, Edwin P. Hui, Anthony T.�C. Chan, Ceri Edwards, Neil Steven, Xiaorong Lin, Rosalie Ho, Deborah Stocken and Stephen L. Chan and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Hui Jia

9 papers receiving 481 citations

Peers

Hui Jia

ONCOL

IMMUN

EPIDE

PFM

MB

Nadine Meru Germany

Jingwu Xu Canada

Carrie B. Coleman United States

Alice Gallagher United Kingdom

Elena Vendrame United States

Pooi Pooi Leong Malaysia

G Henle Sweden

Fung Lam United States

W Henle United States

Lina Ghabreau Syria

Nadine Meru Germany

Hui Jia

319 ×0.8

ONCOL

83 ×0.3

IMMUN

110 ×0.9

EPIDE

146 ×1.3

PFM

39 ×0.8

MB

Citations per year, relative to Hui Jia Hui Jia (= 1×) peers Nadine Meru

Countries citing papers authored by Hui Jia

Since Specialization

Citations

This map shows the geographic impact of Hui Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Jia more than expected).

Fields of papers citing papers by Hui Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Jia. The network helps show where Hui Jia may publish in the future.

Co-authorship network of co-authors of Hui Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Jia. A scholar is included among the top collaborators of Hui Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Jia. Hui Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Xiao, Shaobo, et al.. (2025). Efficient blocking ELISA for bovine alphaherpesvirus 1 using a gB epitope–specific monoclonal antibody. Journal of Veterinary Diagnostic Investigation. 37(5). 786–799.

2.

Zhang, Ying, Hua Chen, Hui Jia, et al.. (2024). Electrophysiological Mechanism of Catestatin Antiarrhythmia: Enhancement of I _to , I _K, and I _K1 and Inhibition of I _Ca _‐L in Rat Ventricular Myocytes. Journal of the American Heart Association. 13(16). e035415–e035415. 1 indexed citations

3.

Han, Bo, et al.. (2019). Comparative studies of mucosal humoral and cellular immune responses to 2009 pandemic H1N1 influenza virus in mice. Acta Virologica. 63(2). 203–210. 2 indexed citations

4.

Taylor, Graham S., Hui Jia, Kevin J. Harrington, et al.. (2014). A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer. Clinical Cancer Research. 20(19). 5009–5022. 138 indexed citations

5.

Hui, Edwin P., Graham S. Taylor, Hui Jia, et al.. (2013). Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients. Cancer Research. 73(6). 1676–1688. 146 indexed citations

6.

Long, Heather M., Jianmin Zuo, Alison M. Leese, et al.. (2009). CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus–transformed B cells. Blood. 114(4). 807–815. 24 indexed citations

7.

Bell, Andrew, Hui Jia, Debbie Croom-Carter, et al.. (2008). The Effects of Acute Malaria on Epstein-Barr Virus (EBV) Load and EBV-Specific T Cell Immunity in Gambian Children. The Journal of Infectious Diseases. 199(1). 31–38. 68 indexed citations

8.

Haigh, Tracey A., Xiaorong Lin, Hui Jia, et al.. (2008). EBV Latent Membrane Proteins (LMPs) 1 and 2 as Immunotherapeutic Targets: LMP-Specific CD4+ Cytotoxic T Cell Recognition of EBV-Transformed B Cell Lines. The Journal of Immunology. 180(3). 1643–1654. 53 indexed citations

9.

Lin, Xiaorong, Nancy Gudgeon, Edwin P. Hui, et al.. (2007). CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients. Cancer Immunology Immunotherapy. 57(7). 963–975. 37 indexed citations

10.

Lin, Xiaorong, Nancy Gudgeon, Graham S. Taylor, et al.. (2006). CD4⁺T-Cell Responses to Epstein-Barr Virus Nuclear Antigen EBNA1 in Chinese Populations Are Highly Focused on Novel C-Terminal Domain-Derived Epitopes. Journal of Virology. 80(16). 8263–8266. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact